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ABSTRACT
The broad aim of biomedical science in the
postgenomic era is to link genomic and phenotype
information to allow deeper understanding of the
processes leading from genomic changes to
altered phenotype and disease. The EuroPhenome
project (http://www.EuroPhenome.org) is a compre-
hensive resource for raw and annotated high-
throughput phenotyping data arising from projects
such as EUMODIC. EUMODIC is gathering data from
the EMPReSSslim pipeline (http://www.empress
.har.mrc.ac.uk/) which is performed on inbred
mouse strains and knock-out lines arising from the
EUCOMM project. The EuroPhenome interface
allows the user to access the data via the phenotype
or genotype. It also allows the user to access the
data in a variety of ways, including graphical display,
statistical analysis and access to the raw data via
web services. The raw phenotyping data captured in
EuroPhenome is annotated by an annotation
pipeline which automatically identifies statistically
different mutants from the appropriate baseline
and assigns ontology terms for that specific test.
Mutant phenotypes can be quickly identified using
two EuroPhenome tools: PhenoMap, a graphical
representation of statistically relevant phenotypes,
and mining for a mutant using ontology terms.
To assist with data definition and cross-database
comparisons, phenotype data is annotated using
combinations of terms from biological ontologies.
INTRODUCTION
The laboratory mouse is fundamental to the understand-
ing of mammalian biology and the investigation of human
disease (1,2). There is now a wealth of genotypic informa-
tion available as a result of the sequencing the mouse
genome, and a central challenge in the identiﬁcation of
mouse disease models is the attribution of function to
individual genes. The classical genetics approach of
relating genotype to phenotype—the introduction of
mutations into the genome of an experimental organism
and the identiﬁcation of novel phenotypes—can be fur-
thered on a high-throughput scale with the establishment
of projects devoted to the manufacture of mouse gene
knockout lines. The International Knockout Mouse
Consortium (IKMC; http://www.knockoutmouse.org)
(3) is made up of the four major projects: (i) EUCOMM
(http://www.eucomm.org), (ii) KOMP (http://www.nih
.gov/science/models/mouse/knockout/), (iii) TIGM
(http://www.tigm.org) and (iv) NorCOMM (http://www
.norcomm.org) and is in the process of gen-
erating mutations in ES cells for all known protein
coding genes.
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(EUMODIC; http://www.eumodic.org) in collaboration
with EUCOMM (4) is in the process of generating
mouse mutant lines from ES cell resource and aims to
provide a phenotype assessment of 500 mouse mutant
lines. The Eumorphia programme (http://www
.eumorphia.org) (5) was the predecessor to EUMODIC
and generated baseline phenotype data for four inbred
mouse lines besides developing the European Mouse
Phenotyping Resource for Standardised Screens
(EMPReSS) (6,7), which can be utilized for mouse
phenotyping. The EuroPhenome Resource (http://www
.EuroPhenome.org) originally contained and presented
the baseline data derived during Eumorphia (8). Our
previous article in NAR described this data and the web
tools we had developed to analyse and display them. Since
this initial eﬀort, EuroPhenome has undergone signiﬁcant
development; most notable is that EuroPhenome now
captures and annotates mutant mouse phenotyping data
from EUMODIC, presenting putative phenovariants to
users.
Three critical steps have been achieved within the
EUMODIC programme, which allow the comprehensive
analysis and interpretation of the generated phenotype
data. First, the phenotype data is generated using
community-agreed phenotyping platforms that provide
standardized methods, so that the results can be
compared between laboratories and over time. All of the
phenotyping procedures executed during the EUMODIC
screens are part of the publicly available EMPReSS
resource (http://empress.har.mrc.ac.uk) and organized
into two phenotyping pipelines, collectively termed
EMPReSSslim (http://www.eumodic.org/EMPReSSslim
.html). Second, the raw phenotype data, which is
generated by the participating research institutions, is
collected within EuroPhenome which serves as a commu-
nity database with open access. And third, ontologies
provide the structured description of the phenotypes
within EuroPhenome to allow the data to be interpreted
in a consistent manner.
DATA IN EUROPHENOME
EMPReSSslim consists of 20 phenotyping screens
described by standard operating procedures (SOPs).
These examine the broad biological domains of body mor-
phology; metabolism, heart morphology and blood
pressure, body fat and bone composition and skeletal
morphology, behaviour and sensory testing, haematology;
clinical chemistry, FACs analysis of leukocytes and
immunoglobulin concentration. Data measured in each
SOP are recorded as individual parameters. The
parameters for each screen are given a unique identiﬁer.
These are listed in EMPReSS. The parameters are of two
types: phenotype parameters and metadata parameters.
The phenotype parameter deﬁnes a characteristic of the
mouse which can be measured and so is analogous to a
mouse trait. The data obtained for each phenotype param-
eter during the execution of the SOP is captured and
analysed within EuroPhenome. Metadata parameters
capture technical aspects of the SOP which could make
an impact in the comparison of phenotype parameters
between executions of the same SOP, for example equip-
ment models and settings. Currently, 622 phenotype
parameters are recorded in the EMPReSSslim screen.
EuroPhenome contains data for 76 mutant mouse
strains (in some cases representing alleles in both
homozygous and heterozygous states), making a total of
2.1million data points.
The mouse clinics (Institut Clinique de la Souris,
France; Helmholtz Zentrum Munich, Germany; MRC
Harwell; and Wellcome Trust Sanger Institute, UK)
which are part of EUMODIC process mutant mouse
lines through EMPReSSslim, capturing the phenotype
data in their local Laboratory Information Management
Systems (LIMS). The database architectures of the various
LIMS diﬀer markedly, so a common data format is
needed for the exchange of data from the LIMS to
EuroPhenome. An XML data format is used for this
purpose whereby the phenotype data for each individual
mouse making up a mutant strain cohort, which
for the EUMODIC project is deﬁned as seven or more
individuals, can be submitted for each procedure carried
out. Each procedure is deﬁned using the Minimal
Information for Mouse Phenotyping Procedures
(MIMPP) standard, which was developed as part of the
larger community-wide eﬀort for minimum information
for biological and biomedical investigations (MIBBI) (9),
and is captured using its associated XML data format.
The phenotype data XML ﬁles are uploaded to the insti-
tution’s FTP site which EuroPhenome scans daily for new
data. Each uploaded XML ﬁle is validated to ensure all
required data points are present and the data for each
parameter is of the correct type.
ANNOTATION PIPELINE
An SOP measures parameters which produce direct
primary phenotype measurements. In combination with
other primary phenotypes, these can be used to infer qual-
itative or descriptive phenotypes. For example, data for a
mutant line for the hotplate test might include a time in
seconds before the ﬁrst response and the observation of a
recognized response to heat. Where the time in seconds is
less than the comparative background strain, the
phenotype of ‘decreased thermal nociceptive threshold’
could be inferred. EuroPhenome describes the traits and
phenotypes using ontologies, where both the pre-
composed Mammalian Phenotype (MP) ontology (10)
and the post-composed Entity and Quality (EQ) PATO
(11) model are employed. The phenotype parameter (or
mouse trait) is deﬁned using EQ; for example, ‘coat
hair’+‘texture’. The resulting phenotype is also deﬁned
using EQ where the phenotype quality is a child term to
parameter quality within the PATO ontology; for example
‘coat hair’+‘greasy’. The quality terms ‘texture’ and
‘greasy’ share a parent-to-child relationship within
PATO. Currently EuroPhenome annotates phenotypes
using MP terms, where each MP term is the closest
equivalent to the EQ phenotype description. The EQ
D578 Nucleic AcidsResearch, 2010, Vol.38,Database issueannotations of parameters and the EQ and MP
annotations of phenotypes are available at http://www
.EuroPhenome.org/parameters.html.
EuroPhenome performs statistical comparisons of
mutant line phenotype parameter data to baseline
inbred strain phenotype parameter data to identify
phenovariants. The statistical comparison takes place
between related datasets only when critical metadata
parameters are identical. Pearson’s Chi-square test of
independence is applied to categorical data and the
Student’s t-test and the Mann–Whitney U test are
applied to quantitative data. These tests were chosen
because they are familiar to the community and
computationally tractable for the size of data set.
Phenovariants are mutant lines which show a phenotype
to be present to a greater or lesser extent compared to the
baseline inbred strains. EuroPhenome stores all possible
annotations and automatically applies the relevant MP
term to the mutant line depending on the direction
(increased or decreased) of the phenovariant. For a
more detailed description of the use of ontologies in the
annotation of EuroPhenome data, refer Beck et al. (12).
EUROPHENOME FUNCTIONALITY
The majority of users access EuroPhenome through the
web interface and so a critical aim of the project has been
to develop visual methods enabling quick and easy data
access. The complexity and size of data generated from
high-throughput phenotyping projects is a new challenge
for bioinformatics and hence new methods and
approaches to displaying this data are required.
EuroPhenome allows users to access the raw data and
the annotated data described above through three new
integrated web tools; the ‘Phenome Data Viewer’, the
‘PhenoMap’ and the ‘Ontology Tree’ Tool. In our
previous NAR paper, we described the data browser for
the visualization of the Eumorphia data; this browser is
still available through the EuroPhenome portal by clicking
on the ‘Eumorphia data browser’ link.
Phenome Data Viewer
The Phenome Data Viewer is the primary tool enabling
users navigate through the raw phenotyping data from
both the inbred mouse strains and the mutant strains to
view dynamically generated graphs and overview statistics
built from user entered selections. The type of graph
displayed is preset depending on the parameter type:
single quantitative parameters are displayed as bar
charts, time series quantitative parameters are shown as
line graphs and qualitative data is displayed in a stacked
bar graph.
The left-hand panel of the viewer displays a number of
selection boxes which the user can click to build the
speciﬁc query of interest. The inbred mouse data option
presents users with a number of choices (centre, strain, sex
and procedure) allowing them to build the speciﬁc query
they are interested in; for example, to compare data
from an EMPReSSlim procedure between two inbred
strains, the user would choose the strains of interest in
the Strains selection box (e.g. C57BL/6NTac and
C57BL/6J), the procedure and parameter/s from the
relevant selection boxes (e.g. IPGTT and Blood glucose
concentration) and click view data. The data view
returned would be a line graph showing how blood
glucose concentration varied over time (Figure 1a). This
data view enables the user to drill further into the data and
view the speciﬁc metadata parameters used when the data
was collected, download the raw data used in generating
the graph as well as viewing overview statistics.
The mutant mouse data viewer enables the user to
choose one or more mutants of interest from the ‘Select
Mutants’ list, before selecting the zygosity of interest, sex
and the procedure and parameter in the same way as
before (e.g. Mysm1, Clinical Chemistry PL1 and HDL
cholesterol). The data view returned to the user comprises
a graph, which now shows the results for the relevant
baseline strain as well as the mutant line split by
zygosity and sex, if chosen. In addition to the graph, the
user can access overview statistics, which include the
mean, standard deviation, standard error, results from
the statistical tests shown as ‘Not signiﬁcant, Signiﬁcant,
Highly Signiﬁcant’ as well as highlighting diﬀerences in
metadata (Figure 1b). The levels for these annotations
are: not signiﬁcant, P>0.05; signiﬁcant, P<0.05; and
highly signiﬁcant, P<0.001.
PhenoMap
Interaction with the scientiﬁc user community in
EUMODIC identiﬁed that the majority of users of
EuroPhenome would want to ask ‘Can I quickly ﬁnd a
phenovariant/s with the phenotype/s of interest?’’. The
PhenoMap (Figure 2) is a graphical representation of sta-
tistically signiﬁcant phenovariants produced from the
annotation pipeline described above. The left-hand panel
of the PhenoMap allows user to view all mutant lines in
EuroPhenome or to choose those of interest. The top
panel has functionality for the user to choose the
phenotyping pipeline (relating to EMPReSSslim) of
interest, the sex, the P value range and the eﬀect size of
interest. Grey boxes in the map depict a procedure for
which we currently do not hold data, the green boxes
depict when data is available but no signiﬁcant
annotations were found at the current P-value and eﬀect
size. The red boxes show a signiﬁcant annotation at the
current P-value and eﬀect size. Further information about
the signiﬁcant annotation can be easily accessed by
hovering over the red box. At this point, the user can
jump directly to the relevant graph in the phenome
viewer. A user can also drill down into a speciﬁc procedure
to view the annotations at a parameter level by clicking on
the procedure name.
Ontology Tree
The ‘Ontology Tree’ tool enables the user to move
through the MP ontology tree to view ontology
annotations produced from the annotation pipeline for
each line (Figure 3). Selecting a MP term of interest
displays a table in the right-hand panel showing the
mutant line, the procedure, the parameter and the
Nucleic Acids Research, 2010,Vol.38, Database issue D579Figure 1. This interface shows the results of two queries using the Phenome Data Viewer. (A) The query builder menu on the left-hand side and the
results panel on the right which displays a line graph of Blood glucose concentration from the Intraperitoneal glucose tolerance test (IPGTT)
procedure performed on inbred mouse strains C57BL/6Ntac and C57BL/6J. (B) The same query builder for mutant data on the left-hand side and on
the right, the bar chart graph of HDL-cholesterol for the Mysm-1 mutant.
D580 Nucleic AcidsResearch, 2010, Vol.38,Database issueontology term it was annotated with. Again, the user can
quickly jump to the phenome data viewer graph of interest
by clicking on the graph link.
IMPLEMENTATION
The XML generation, validation and export is automated
using a Java library available under the GPL at
http://sourceforge.net/projects/EuroPhenome/. This is
implemented at the mouse clinics and allows a common
process of validation and XML generation as well as
minimizing the work required to export data to
EuroPhenome.
When new data is entered into EuroPhenome, a number
of processes are automatically performed. The annotation
pipeline is implemented as a Java application that uses the
same code that generates the statistical information on the
website. If a statistically signiﬁcant phenovariant is dis-
covered, the data is inserted into a database called the
Ontology Annotation sysTem at Harwell (OATH). This
stores information about the mutant (such as gene aﬀected
and zygosity of group showing diﬀerence), the parameter
and detected trait along with the results of the statistical
test. This allows the ontology visualization tools to tailor
the result to the user-speciﬁed values.
If new mutant lines are uploaded, a number of resources
are used to collect the genotype information. These
include the external web services of EUCOMM, EMMA
and KERMITS for EUCOMM lines and an internal copy
of the MGI database for non-EUCOMM lines.
The EuroPhenome database is implemented in MySQL
(http://www.mysql.com/) running on Solaris, and
interacts with the OATH and EMPReSS databases
running on the same platform. The Phenome Data
Viewer is implemented as a Java Servlet and the
PhenoMap and Ontology Tree are implemented in PHP.
The website is styled using css. The Ontology Tree uses
DHTML and AJAX to provide the relevant information
as the tree is traversed, and an auto suggest function to
ﬁnd a term of interest. The PhenoMap uses JavaScript to
provide user functionality, including the Prototip library
to provide the hover-over information. The Phenome
Data Viewer uses JavaScript to provide the user ﬁl-
ter selection, including providing the user with only
relevant options depending on their selection. The
images are generated by JFreeChart (http://www.jfree
.org/jfreechart/). Memcached (http://www.danga
.com/memcached/) is used to improve performance.
The statistics are calculated using the Apache Commons
Math library for the Pearson’s chi-square test, Student’s
t-test and the descriptive statistics, and the Java Statistical
Classes library for the Mann–Whitney U-test.
FUTURE DIRECTIONS
The systematic acquisition of phenotype data on mutant
mouse lines will be central to the functional annotation of
Figure 2. This interface shows the EuroPhenome PhenoMap tool, which is a heatmap representation of statistically signiﬁcant phenovariants
produced from the annotation pipeline. The top panel is an interactive tool to change the phenotyping pipeline (relating to EMPReSS) of
interest, the sex, the P range and the eﬀect size. Grey boxes in the map depict a procedure for which we currently do not hold data, the green
boxes depict when data is available but no signiﬁcant annotations were found at the current P-value and eﬀect size. The red boxes show a signiﬁcant
annotation at the current P-value and eﬀect size. Further details on red boxes can be obtained by hovering over the box.
Nucleic Acids Research, 2010,Vol.38, Database issue D581the mouse genome over the coming decades (13,14). These
data will be equivalent to that produced by genome
projects in providing the fundamental information upon
which detailed characterization of mammalian gene
function can be built. Because of the fundamental role
of these resources there is a strong move to make both
material mouse resources and data about them freely
accessible (15). The EUMODIC consortium is laying the
foundations of this phenotyping eﬀort but wider plans are
being developed to build an International Mouse
Phenotype Consortium (IMPC) to carry out this system-
atic phenotyping.
Both physical and bioinformatics infrastructure will be
needed to support such a major project. EuroPhenome
represents the ﬁrst step towards developing the
bioinformatics infrastructure. Major developments can
be expected in future in ways of collecting, representing
and visualizing phenotype data in conjunction with other
data, such as genomic data, to make them more readily
interpretable by the bench biologist. Novel modes of data
analysis, including a more reﬁned approach to statistical
analysis, will also be needed to provide the maximum
value from phenotyping data. EuroPhenome aims to
extend its scope beyond EUMODIC to allow systemati-
cally acquired phenotype data from diﬀerent sources to be
presented within the same framework, adding value to all
of these data sets by integrating them with others.
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